Merrimack Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch MACK and buy or sell other stocks, ETFs, and their options commission-free!

About MACK

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310.

CEO

Gary L. Crocker, MBA

CEOGary L. Crocker, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1993

Founded1993

Employees

—

Employees—

MACK Key Statistics

Market cap

219.87M

Market cap219.87M

Price-Earnings ratio

-8.91

Price-Earnings ratio-8.91

Dividend yield

—

Dividend yield—

Average volume

515.00K

Average volume515.00K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$15.89

52 Week high$15.89

52 Week low

$11.53

52 Week low$11.53

People also own

Based on the portfolios of people who own MACK. This list is generated using Robinhood data, and it’s not a recommendation.